Lisinopril vs Tofacitinib
Lisinopril vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Lisinopril and Tofacitinib.
Mechanism of Action
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Lisinopril — 12 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Lisinopril — C21H31N3O5; Tofacitinib — C16H20N6O.
Molecular Weight: Lisinopril — 405.4900 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Lisinopril — Small molecule; Tofacitinib — Small molecule.